Certified by Founder Lodge 
                                        
                                        Point72
 
                                                 United States  -  Stamford, Connecticut 
                                             INVESTOR 
                                            
                                                                                    1 Disclosed Funding Rounds $20,000,000
                                            4 Participating Investments
- 
                                                Operating Status 
                                                
Active
 - 
                                                Last Funding Type 
                                                
Seed
 - 
                                                Company Type 
                                                
For Profit
 - Website
 - Contact
 - Social Links
 
                                            Point72 Asset Management is a global firm led by Steven Cohen that invests in multiple asset classes and strategies worldwide. Resting on more than a quarter-century of investing experience,
                                        
                                        
                                        
                                                                                
                                        
                                        
                                        
                                        
                                                                                
                                        | Company | Date | Round | Raised | 
|---|---|---|---|
   Lexion | 
                                                            April, 20 ,2023 | Series B | $20,000,000 | 
   Saronic Technologies | 
                                                            October, 10 ,2023 | Series A | $55,000,000 | 
   Alto Neuroscience | 
                                                            November, 22 ,2023 | Series C | $45,000,000 | 
   Mirador Therapeutics | 
                                                            March, 26 ,2024 | Unknown | $400,000,000 | 
                                                
  Lexion
  Saronic Technologies
  Alto Neuroscience
  Mirador Therapeutics
Founderpath
Truework
Finix
Farther
TeamApt Inc.
                                                                        
                                Helex |  $3,500,000  | (Nov 4, 2025)
                                                                        
                                xMEMS |  $21,000,000  | (Nov 4, 2025)
                                                                        
                                catalyx space |  $5,400,000  | (Nov 4, 2025)
                                                                        
                                Cephia AI |  $4,000,000  | (Nov 4, 2025)
                                                                        
                                Ornn |  $5,700,000  | (Nov 4, 2025)